Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a C-14-microtracer and therapeutic dose in cancer patients (vol 81, pg 39, 2017)

van Andel L.<sup>*</sup>; Rosing H.; Zhang Z.; Hughes L.; Kansra V.; Sanghvi M.; Tibben M. M.; Gebretensae A.; Schellens J. H. M.; Beijnen J. H.

doi:10.1007/s00280-017-3474-7

登录

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a C-14-microtracer and therapeutic dose in cancer patients (vol 81, pg 39, 2017)

作者：van Andel L.^*; Rosing H.; Zhang Z.; Hughes L.; Kansra V.; Sanghvi M.; Tibben M. M.; Gebretensae A.; Schellens J. H. M.; Beijnen J. H.

来源：Cancer Chemotherapy and Pharmacology, 2018, 81(1): 47-47.

DOI：10.1007/s00280-017-3474-7

摘要

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a C-14-microtracer and therapeutic dose in cancer patients'', written by L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens and J. H. Beijnen, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 17th October 2017 without open access.